DEA's Own Pharmacologist Challenged the Scientific Basis for Marijuana Rescheduling
A federal pharmacologist who authored the Drug Enforcement Administration's 2024 Scientific Data Review testified under subpoena during the ongoing marijuana rescheduling hearing - and her